Journal profile · Immunology
Immunological Reviews
ISSN 0105-2896 · eISSN 1600-065X · Wiley-Blackwell Publishing Ltd · DENMARK · Bimonthly
Immunological Reviews: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 10.51; hybrid open access; APC about USD 5,000; median 34 days to acceptance (71 articles, last 24 months); community-reported acceptance: mostly invited papers; 115 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Immunological Reviews is published by Wiley-Blackwell Publishing Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are T-cell and B-cell Immunology, Immune Cell Function and Interaction and Immunotherapy and Immune Responses, together about 58.5% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
While each volume of Immunological Reviews is devoted to a single topic of immunological research, collectively their aim is to provide a broad and continuously updated survey of advances in basic immunology and their clinical applications.
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief John CambierPublisher website
Editorial board by country: none in mainland China; most named United States 2, Sweden 1 (3 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- T-cell and B-cell ImmunologyImmunology and Microbiology24.2%
- Immune Cell Function and InteractionImmunology and Microbiology22.9%
- Immunotherapy and Immune ResponsesImmunology and Microbiology11.4%
- Monoclonal and Polyclonal Antibodies ResearchMedicine5.7%
- Immune Response and InflammationImmunology and Microbiology5.2%
- CAR-T cell therapy researchMedicine3.1%
- Immunodeficiency and Autoimmune DisordersImmunology and Microbiology2.6%
- IL-33, ST2, and ILC PathwaysImmunology and Microbiology2.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, AGRICOLA
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 10.51LetPub ·
- Impact factor (publisher)
- 10.6Publisher website ·
- Impact factor (publisher) 2025
- 10.6Publisher website ·
- CiteScore 2026-06
- 17LetPub ·
- CiteScore (publisher)
- 17Publisher website ·
- CiteScore (publisher) 2025
- 17Publisher website ·
- SJR 2026-06
- 3.95LetPub ·
- SNIP 2026-06
- 1.9LetPub ·
- h-index
- 197LetPub ·
- h-index
- 323OpenAlex ·
- i10-index
- 4,128OpenAlex ·
- 2-year mean citedness
- 10.52OpenAlex ·
- Self-citation rate
- 1.9%LetPub ·
- Share of gold OA articles
- 49.15%LetPub ·
Volume
- Articles per year
- 79LetPub ·
- Articles per year (publisher) 2025
- 92Publisher website ·
- Downloads per year (publisher) 2025
- 942,245Publisher website ·
Articles by year OpenAlex count · 5,043 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 97 | 73 | 150 |
| 2025 | 115 | 90 | 1,004 |
| 2024 | 136 | 121 | 2,507 |
| 2023 | 131 | 100 | 3,987 |
| 2022 | 133 | 86 | 5,075 |
| 2021 | 117 | 74 | 4,481 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
34 daysMedian, submission to acceptance · P25–P75 14 days – 61 days
- Acceptance to online
- median 18 days (72 articles)
- Submission to online
- median 56 days
- Sample
- 71 articles with submission and acceptance dates (229 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- Mostly invited papersLetPub ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,000 / EUR 4,150 / GBP 3,300 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- First submission
- Free format: the journal's layout is not required
Article types accepted2, with length limits
- invited reviewInvited Review Word limit: The articles should be 10000-14000 words (approximately 45 double spaced manuscript pages. Summary: 200-word summary of the article. …Length not stated
- reviewImmunological Reviews does not accept unsolicited manuscripts.main text ≤ 14,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints
- Authorship Authorship
Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Source ↗Publisher website ·- Data availability Expects Data Sharing
Please review Wiley’s policy here. This journal expects and peer review data sharing.
Source ↗Publisher website ·- Publication ethics Publication Ethics
Member of COPE Model summary
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
Source ↗Publisher website ·- Open access Publishing Open Access? Your fees may be covered
Click on the Altmetric banner to view the latest trending articles from Immunological Reviews
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are reviewed by the Guest Editor. If papers submitted include the Guest Editor as co-author the Editor-in-Chief will review the paper.
Source ↗Publisher website ·- Plagiarism
Uses iThenticate CrossCheck Model summary
Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts.
Source ↗Publisher website ·- Preprints
Preprint policy Model summary
This journal accepts articles previously published on preprint servers. Immunological Reviews will consider for review articles previously available as preprints.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- DENMARK
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 0105-2896
- Electronic ISSN
- 1600-065X
- Latest issue on the website
- Volume 342, Issue 1 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Immunological Reviews
What CAS zone is Immunological Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Immunological Reviews is in Zone 2 of Medicine, and in Zone 2 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Immunological Reviews?
The latest impact factor listed by LetPub is 10.51; CiteScore 17, h-index 323.
How long does peer review take at Immunological Reviews?
Based on the dates recorded on 71 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 34 days (interquartile range 14–61 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Mostly invited papers”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Immunological Reviews based?
Of the 3 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (2) and Sweden (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Immunological Reviews?
According to LetPub and DOAJ records, Immunological Reviews is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Immunological Reviews open access, and what is the APC?
Immunological Reviews is a hybrid journal. For open-access publication: APC about USD 5,000.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .